The US Food and Drug Administration has approved the marketing of a device that uses AI to determine whether a person with diabetes has more than mild diabetic retinopathy. It is the first time such […]
The U.S. Food and Drug Administration (FDA) granted Genentech, a Roche company, Breakthrough Therapy Designation for Hemlibra (emicizumab-kxwh) for hemophilia A without factor VIII inhibitors. The designation was based on results from the Phase III […]
GlaxoSmithKline (GSK) has signed a strategic agreement to transfer its rare disease gene therapy portfolio to Orchard Therapeutics, following a review of the rare disease unit in July 2017. GSK will take a 19.9% equity […]
While only 5 percent to 10 percent of cancers are caused by an inherited gene mutation, genetic testing may benefit people with a strong history of family cancer, an expert in genetics suggests. This is […]
Sanofi is planning to build a new €350m vaccines manufacturing facility at its Canadian headquarters in Toronto. The expansion is expected to significantly bolster its paediatric and booster vaccines capacity to meet the emerging demands. […]